First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Clinical trial NCT05103683 · RECRUITING
Trial details
- NCT number
- NCT05103683
- Sponsor
- TORL Biotherapeutics, LLC
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-17
- Primary completion
- 2026-08-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.